Janus Henderson Group PLC Revolution Medicines, Inc. Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,640,218 shares of RVMD stock, worth $281 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
4,640,218
Previous 3,912,119
18.61%
Holding current value
$281 Million
Previous $126 Million
42.83%
% of portfolio
0.1%
Previous 0.07%
Shares
10 transactions
Others Institutions Holding RVMD
# of Institutions
251Shares Held
161MCall Options Held
188KPut Options Held
103K-
Vanguard Group Inc Valley Forge, PA14.4MShares$871 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA13.7MShares$828 Million0.1% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$813 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA9.76MShares$591 Million1.83% of portfolio
-
Baker Bros. Advisors LP New York, NY7.57MShares$459 Million3.9% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $5.31B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...